April 28, 2026, marks a monumental shift in U.S. cannabis history. Following the Acting Attorney General’s final order, the Drug Enforcement Administration (DEA) has officially moved FDA-approved marijuana drugs and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).
For state-authorized medical cultivators, processors, and dispensaries, this move unlocks unprecedented financial benefits and creates a historic pathway to federal compliance. However, federal authorization introduces new DEA registration requirements.
Here is what state-licensed operators need to know to navigate the Schedule III landscape and exactly how to apply for federal registration.
1. Immediate Relief from IRS Section 280E Tax Penalties
The most immediate win for the industry is the removal of the IRS Section 280E burden. Since 280E only applies to businesses “trafficking” in Schedule I or II substances, state-licensed medical providers are now exempt. Current guidance suggests that for the 2026 tax year, the relief applies to the entire taxable year. The DEA has also encouraged the Treasury to consider retrospective relief for prior tax years where businesses operated under a valid state medical license.
2. Expedited DEA Registration for State Licensees
The DEA has established a “Fast-Track” federal registration pathway for businesses already holding state medical marijuana licenses.
Application Window: Submit within 60 days of publication (by June 27, 2026) for priority review.
Interim Operations: Applicants may continue operations under their state licenses while the DEA reviews the application.
Review Goal: The DEA aims to process early applications within six months.
Annual Fees: Manufacturers ($3,699), Distributors ($1,850), Dispensers ($888 every 3 years).
Contact CannDelta today to Fast-Track your DEA medical marijuana registration!
| Business Activities | Registration Period | Annual Fee | Application Form |
| Manufacturer | 1 Year | $3,699 | Form 225 |
| Distributor | 1 Year | $1,850 | Form 225 |
| Dispenser | 3 Years | $888 ($296/yr) | Form 224 |
| Researcher | 1 Year | $296 | Form 225 |
3. Deference to State Regulatory Frameworks
To avoid “double regulation,” the DEA is adopting a cooperative approach. In many cases, if you are compliant with state law, you are considered compliant with federal Schedule III standards for physical security, packaging, and record-keeping. State labels are accepted, provided they now include the statutory federal warning label.
4. International Treaty Compliance (The "Catch")
To satisfy the Single Convention on Narcotic Drugs, the DEA must maintain a “government monopoly” on wholesale trade. Registered manufacturers must establish a nominal price for crops, which the DEA will technically “purchase” and immediately “sell” back to the entity for a small administrative fee. Manufacturers must also allow the DEA on-demand access to storage facilities until this transaction is finalized.
5. What Stays in Schedule I?
- Adult-Use (Recreational) Marijuana: Federal Schedule III status currently only applies to medical marijuana. 280E still applies to recreational-only businesses.
- Synthetics: Synthetically derived THC (e.g., Delta-10) remains Schedule I.
- Unlicensed Bulk Material: Any marijuana not part of a state-licensed medical chain remains federally prohibited.
How to Apply: The DEA Medical Marijuana Registration Process
To take advantage of the expedited review, applicants must complete a comprehensive 7-section online registration with the DEA. Before submission, applicants must pay an annual $794 application fee.
Here is what you must prepare to submit:
- Section 1: Personal & Business Information: Standard business details, ownership structure, and whether primary ownership has changed in the past 12 months.
- Section 2: Activity Details: You must declare the specific drug codes you are handling (e.g., FDA-approved/state-licensed marijuana [Code 7362], extracts [Code 7353], or naturally derived delta-9-THC [Code 7386]). You must also specify whether you will handle medical or recreational marijuana.
- Section 3: State License(s): Input your active state license number and expiration date.
- Section 4: Liability Questions: Full disclosure regarding any past criminal convictions connected to controlled substances, surrendered registrations, or exclusions from state health programs for the applicant, officers, partners, and stockholders.
- Section 5: Compliance Information (The Heaviest Lift): You must provide DEA registration numbers for all intended suppliers. Crucially, you must confirm that your facility has formal Standard Operating Procedures (SOPs) in place for ordering, receiving, inventories, storage, security, dispensing, destruction, theft/loss reporting, and due diligence. You must also list personal details and disciplinary histories of every individual with access to controlled substances, and check off your facility’s physical security measures (e.g., vaults, safes, access controls, alarms).
- Sections 6 & 7: Payment and Submission: Review your submission, pay the non-refundable $794 fee (currently via PayPal), and submit electronically to receive your confirmation.
Secure Your Federal Future Today
The 60-day window for expedited review is closing on June 27, 2026. Transitioning a state-licensed facility to a federally recognized Schedule III operation is complex. Compiling the required SOPs, detailing compliance data, and ensuring your physical facility meets strict federal security standards is a massive undertaking. A single mistake or missing SOP on your application can delay your federal approval and impact your interim operational status.
Let CannDelta’s regulatory and scientific experts guide you through the 7-step DEA submission process, audit your facility, and bulletproof your Standard Operating Procedures (SOPs) to ensure federal compliance.
Call us today at +1 877-274-6777 or fill out our contact form below, to fast-track your DEA medical marijuana registration.
Disclaimer: The information provided in this article is for informational purposes only and does not constitute legal or tax advice. While the DEA’s final rule states that state medical marijuana licensees will no longer be subject to the IRS Section 280E deduction disallowance, the DEA explicitly notes that nothing in this rule constitutes a formal determination regarding federal tax liability. Qualifying state licensees should consult with qualified tax counsel regarding the applicability of Section 280E and retrospective tax relief to their specific circumstances.
Frequently Asked Questions
Does moving to Schedule III provide tax relief for my cannabis business?
Yes. State-licensed medical marijuana providers are now exempt from the IRS Section 280E tax deduction disallowance, which only penalizes businesses trafficking in Schedule I or II substances. Current guidance suggests this relief applies to the entire 2026 taxable year, and the DEA has encouraged the Treasury to consider retrospective relief for prior years. *(Disclaimer: The DEA notes that nothing in the rule constitutes a formal determination regarding federal tax liability, and qualifying state licensees should consult with tax counsel).
Does this rescheduling apply to recreational (adult-use) marijuana?
No. The Schedule III designation and the expedited federal registration pathway strictly apply to FDA-approved drug products and marijuana subject to a state medical marijuana license. Registrations under this new subpart do not authorize the manufacture, distribution, or dispensing of marijuana for non-medical or recreational purposes. Adult-use marijuana remains a Schedule I controlled substance.
Are synthetically derived THCs, like Delta-10, included in the Schedule III move?
No. Synthetically derived tetrahydrocannabinols (such as delta-10-THC) are excluded from the Controlled Substances Act’s definition of marijuana because they are derived through artificial synthesis. Therefore, synthetic THC remains in Schedule I
How quickly will the DEA process federal registrations for state-licensed businesses?
The DEA has established an expedited “Fast-Track” review process for entities holding state medical marijuana licenses. The agency aims to process applications submitted within 60 days of the rule’s publication (by June 27, 2026) within six months. Crucially, businesses that apply within this 60-day window can lawfully continue operations under their state licenses while the DEA reviews their application.
What is the DEA "Purchase-Resale" requirement for manufacturers?
Because the United States must comply with the Single Convention on Narcotic Drugs, the federal government must maintain a monopoly on the wholesale trade of marijuana. To satisfy this, registered manufacturers must establish a nominal price for their crops. The DEA will then technically “purchase” the crop and immediately “sell” it back to the manufacturer with a small administrative fee added.
Will the DEA accept my state-mandated packaging, labeling, and security measures?
Generally, yes. To reduce the federal regulatory burden, the DEA allows registrants to rely heavily on existing state laws. You are considered compliant with federal Schedule III standards for physical security, packaging, labeling, and disposal as long as you meet the requirements of your state law. The only major addition is that your labeling must now include the statutory federal warning label.
